— Know what they know.
Not Investment Advice

KRRO NASDAQ

Korro Bio, Inc.
1W: +1.1% 1M: -19.9% 3M: +0.8% YTD: +39.1% 1Y: -30.8% 3Y: -37.8% 5Y: -97.4%
$11.61
+0.41 (+3.66%)
 
Weekly Expected Move ±8.7%
$8 $9 $10 $11 $12
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 37 · $115.6M mcap · 6M float · 3.14% daily turnover · Short 58% of daily vol

Balance Sheet Trends

Total Assets
$114M -49.8% ▼
5Y CAGR: -15.6%
Total Liabilities
$62M -5.7% ▼
5Y CAGR: -3.0%
Shareholders Equity
$51M -67.9% ▼
5Y CAGR: -23.2%
Cash & Investments
$75M -40.4% ▼
5Y CAGR: -19.4%
Total Debt
$43M -2.9% ▼
5Y CAGR: -1.1%
Net Debt
$22M +299.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$80M$37M$166M$56M$22M
Short-Term Investments$51M$19M$0$70M$53M
Cash & ST Investments$131M$56M$166M$126M$75M
Net Receivables$144K$0$0$2M$969K
Inventory$0$0$0$0$0
Other Current Assets$1M-$376K$4M$4M$6M
Total Current Assets$135M$57M$173M$132M$82M
Property, Plant & Equip.$37M$12M$43M$52M$16M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$13M$5M$0$37M$0
Other Non-Current Assets$320K$228K$6M$6M$15M
Total Non-Current Assets$51M$17M$49M$95M$31M
Total Assets$185M$74M$222M$226M$114M
— Liabilities —
Accounts Payable$3M$3M$7M$4M$2M
Short-Term Debt$3M$3M$0$0$3M
Deferred Revenue$0$0$0$4M$8M
Other Current Liabilities$2M$551K$395K$4M-$221K
Total Current Liabilities$11M$9M$19M$15M$12M
Long-Term Debt$14M$164M$0$0$0
Other Non-Current Liab.$87K$0$1M$1M$1M
Total Non-Current Liabilities$43M$164M$32M$51M$50M
Total Liabilities$55M$173M$52M$66M$62M
— Equity —
Common Stock$35K$0$8K$9K$9K
Retained Earnings-$180M-$102M-$183M-$267M-$384M
Accumulated OCI-$62K-$5K-$0$268K$212K
Total Stockholders Equity$131M-$99M$170M$160M$51M
Total Liabilities & Equity$185M$74M$222M$226M$114M
— Key Metrics —
Total Debt$46M$167M$33M$45M$43M
Net Debt-$34M$130M-$133M-$11M$22M
Total Investments$64M$23M$0$107M$53M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms